Global CAR T-Cell Therapy Market Research Report 2022

Publisher Name :
Date: 04-Aug-2022
No. of pages: 94
Inquire Before Buying

This report aims to provide a comprehensive presentation of the global market for CAR T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell Therapy.

The CAR T-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global CAR T-Cell Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR T-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Novartis

- Gilead Sciences

- Bristol-Myers Squibb

- J & J

- JW Therapeutics

- FOSUNKite

- CARsgen Therapeutics (Pipeline)

- Autolus Therapeutics(Pipeline)

- Sorrento Therapeutics(Pipeline)

- Mustang Bio(Pipeline)

- Bluebird Bio(Pipeline)

- Cellectis(Pipeline)

- Allogene Therapeutics(Pipeline)

- Celyad(Pipeline)

Product Type Insights

Global markets are presented by CAR T-Cell Therapy type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the CAR T-Cell Therapy are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

CAR T-Cell Therapy segment by Type

- CD19 - Targeted

- BCMA - Targeted

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the CAR T-Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the CAR T-Cell Therapy market.

CAR T-Cell Therapy Segment by Application

- Lymphoma

- Multiple Myeloma

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the CAR T-Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR T-Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of CAR T-Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the CAR T-Cell Therapy industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR T-Cell Therapy.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of CAR T-Cell Therapy companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global CAR T-Cell Therapy Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CD19 - Targeted
1.2.3 BCMA - Targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Market Perspective (2017-2028)
2.2 CAR T-Cell Therapy Growth Trends by Region
2.2.1 CAR T-Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 CAR T-Cell Therapy Market Dynamics
2.3.1 CAR T-Cell Therapy Industry Trends
2.3.2 CAR T-Cell Therapy Market Drivers
2.3.3 CAR T-Cell Therapy Market Challenges
2.3.4 CAR T-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
3.4 Global CAR T-Cell Therapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2021
3.5 CAR T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028)
5 CAR T-Cell Therapy Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America CAR T-Cell Therapy Market Size (2017-2028)
6.2 North America CAR T-Cell Therapy Market Size by Country (2017-2022)
6.3 North America CAR T-Cell Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Market Size (2017-2028)
7.2 Europe CAR T-Cell Therapy Market Size by Country (2017-2022)
7.3 Europe CAR T-Cell Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific CAR T-Cell Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America CAR T-Cell Therapy Market Size (2017-2028)
9.2 Latin America CAR T-Cell Therapy Market Size by Country (2017-2022)
9.3 Latin America CAR T-Cell Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell Therapy Introduction
11.1.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell Therapy Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Business (2017-2022)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2017-2022)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell Therapy Introduction
11.4.4 J & J Revenue in CAR T-Cell Therapy Business (2017-2022)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell Therapy Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Business (2017-2022)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Detail
11.8.2 Autolus Therapeutics(Pipeline) Business Overview
11.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Introduction
11.8.4 Autolus Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.8.5 Autolus Therapeutics(Pipeline) Recent Development
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Detail
11.9.2 Sorrento Therapeutics(Pipeline) Business Overview
11.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Introduction
11.9.4 Sorrento Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.9.5 Sorrento Therapeutics(Pipeline) Recent Development
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Detail
11.10.2 Mustang Bio(Pipeline) Business Overview
11.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Introduction
11.10.4 Mustang Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.10.5 Mustang Bio(Pipeline) Recent Development
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Detail
11.11.2 Bluebird Bio(Pipeline) Business Overview
11.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Introduction
11.11.4 Bluebird Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.11.5 Bluebird Bio(Pipeline) Recent Development
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Detail
11.12.2 Cellectis(Pipeline) Business Overview
11.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Introduction
11.12.4 Cellectis(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.12.5 Cellectis(Pipeline) Recent Development
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Detail
11.13.2 Allogene Therapeutics(Pipeline) Business Overview
11.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Introduction
11.13.4 Allogene Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.13.5 Allogene Therapeutics(Pipeline) Recent Development
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Detail
11.14.2 Celyad(Pipeline) Business Overview
11.14.3 Celyad(Pipeline) CAR T-Cell Therapy Introduction
11.14.4 Celyad(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.14.5 Celyad(Pipeline) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of CD19 - Targeted
Table 3. Key Players of BCMA - Targeted
Table 4. Global CAR T-Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global CAR T-Cell Therapy Market Share by Region (2017-2022)
Table 8. Global CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global CAR T-Cell Therapy Market Share by Region (2023-2028)
Table 10. CAR T-Cell Therapy Market Trends
Table 11. CAR T-Cell Therapy Market Drivers
Table 12. CAR T-Cell Therapy Market Challenges
Table 13. CAR T-Cell Therapy Market Restraints
Table 14. Global CAR T-Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global CAR T-Cell Therapy Market Share by Players (2017-2022)
Table 16. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Table 17. Ranking of Global Top CAR T-Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Therapy Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global CAR T-Cell Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
Table 29. Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global CAR T-Cell Therapy Revenue Market Share by Application (2023-2028)
Table 31. North America CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Novartis Company Detail
Table 42. Novartis Business Overview
Table 43. Novartis CAR T-Cell Therapy Product
Table 44. Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 45. Novartis Recent Development
Table 46. Gilead Sciences Company Detail
Table 47. Gilead Sciences Business Overview
Table 48. Gilead Sciences CAR T-Cell Therapy Product
Table 49. Gilead Sciences Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 50. Gilead Sciences Recent Development
Table 51. Bristol-Myers Squibb Company Detail
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb CAR T-Cell Therapy Product
Table 54. Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. J & J Company Detail
Table 57. J & J Business Overview
Table 58. J & J CAR T-Cell Therapy Product
Table 59. J & J Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 60. J & J Recent Development
Table 61. JW Therapeutics Company Detail
Table 62. JW Therapeutics Business Overview
Table 63. JW Therapeutics CAR T-Cell Therapy Product
Table 64. JW Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 65. JW Therapeutics Recent Development
Table 66. FOSUNKite Company Detail
Table 67. FOSUNKite Business Overview
Table 68. FOSUNKite CAR T-Cell Therapy Product
Table 69. FOSUNKite Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 70. FOSUNKite Recent Development
Table 71. CARsgen Therapeutics (Pipeline) Company Detail
Table 72. CARsgen Therapeutics (Pipeline) Business Overview
Table 73. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product
Table 74. CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 75. CARsgen Therapeutics (Pipeline) Recent Development
Table 76. Autolus Therapeutics(Pipeline) Company Detail
Table 77. Autolus Therapeutics(Pipeline) Business Overview
Table 78. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 79. Autolus Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 80. Autolus Therapeutics(Pipeline) Recent Development
Table 81. Sorrento Therapeutics(Pipeline) Company Detail
Table 82. Sorrento Therapeutics(Pipeline) Business Overview
Table 83. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 84. Sorrento Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 85. Sorrento Therapeutics(Pipeline) Recent Development
Table 86. Mustang Bio(Pipeline) Company Detail
Table 87. Mustang Bio(Pipeline) Business Overview
Table 88. Mustang Bio(Pipeline) CAR T-Cell Therapy Product
Table 89. Mustang Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. Mustang Bio(Pipeline) Recent Development
Table 91. Bluebird Bio(Pipeline) Company Detail
Table 92. Bluebird Bio(Pipeline) Business Overview
Table 93. Bluebird Bio(Pipeline) CAR T-Cell TherapyProduct
Table 94. Bluebird Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 95. Bluebird Bio(Pipeline) Recent Development
Table 96. Cellectis(Pipeline) Company Detail
Table 97. Cellectis(Pipeline) Business Overview
Table 98. Cellectis(Pipeline) CAR T-Cell TherapyProduct
Table 99. Cellectis(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 100. Cellectis(Pipeline) Recent Development
Table 101. Allogene Therapeutics(Pipeline) Company Detail
Table 102. Allogene Therapeutics(Pipeline) Business Overview
Table 103. Allogene Therapeutics(Pipeline) CAR T-Cell TherapyProduct
Table 104. Allogene Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 105. Allogene Therapeutics(Pipeline) Recent Development
Table 106. Celyad(Pipeline) Company Detail
Table 107. Celyad(Pipeline) Business Overview
Table 108. Celyad(Pipeline) CAR T-Cell TherapyProduct
Table 109. Celyad(Pipeline) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 110. Celyad(Pipeline) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. CD19 - Targeted Features
Figure 3. BCMA - Targeted Features
Figure 4. Global CAR T-Cell Therapy Market Share by Application in 2021 & 2028
Figure 5. Lymphoma Case Studies
Figure 6. Multiple Myeloma Case Studies
Figure 7. CAR T-Cell Therapy Report Years Considered
Figure 8. Global CAR T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global CAR T-Cell Therapy Market Share by Region: 2021 VS 2028
Figure 11. Global CAR T-Cell Therapy Market Share by Players in 2021
Figure 12. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2021
Figure 14. North America CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America CAR T-Cell Therapy Market Share by Country (2017-2028)
Figure 16. United States CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe CAR T-Cell Therapy Market Share by Country (2017-2028)
Figure 20. Germany CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific CAR T-Cell Therapy Market Share by Region (2017-2028)
Figure 28. China CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America CAR T-Cell Therapy Market Share by Country (2017-2028)
Figure 36. Mexico CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa CAR T-Cell Therapy Market Share by Country (2017-2028)
Figure 40. Turkey CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 43. Gilead Sciences Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 44. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 45. J & J Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 46. JW Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 47. FOSUNKite Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 48. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 49. Autolus Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 50. Sorrento Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 51. Mustang Bio(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 52. Bluebird Bio(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 53. Cellectis(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 54. Allogene Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 55. Celyad(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
  • Global Tenosynovitis Drugs Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 92
    Tenosynovitis Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tenosynovitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Nonsteroidal Anti-inflammatory Drugs (NSAIDs) - Antibiotics - Corticos......
  • Global Ephedrine Drug Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 71
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablet - Capsule - Injection Segment by Application - Bronchial Asthma - Other......
  • Global Woman Disease Pharmaceutical Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 95
    Woman Disease Pharmaceutical market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Woman Disease Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - OTC - Prescription Segment by Application......
  • Global Zinc Oxide Bandages Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Zinc Oxide 10% - Zinc Oxide 20% - Others Segment by Application - Orthopedic -......
  • Global Vinca Alkaloids Drugs Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 86
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oncovin - Velban - Navelbine Segment by Application - Lymphoma - Sarcoma......
  • Global Vitamin C Chewable Tablet Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 106
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Fruit Flavour - Other Segment by Application - Adult - Elderly - Children......
  • Global Central Nervous System (CNS) Drug Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 92
    Central Nervous System (CNS) Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Prescription Drugs - OTC Segment b......
  • Global Liver Supplement Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 102
    Liver Supplement market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Liver Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Tablets - Capsules - Others Segment by Application - O......
  • Global Cancer Medication Market Research Report 2022
    Published: 04-Aug-2022        Price: US 2900 Onwards        Pages: 90
    Cancer Medication market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Antimetabolite - Alkaloid Drugs - Hormone - Targeted Drug - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs